Clinton Winslow
Family Medicine · Oklahoma City, OKNPI 1205886744
Payments from drug & device makers
Across 142 payments — averaging $17.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$555
- GSK$325
- Novo Nordisk$306
- Lilly USA, LLC$302
- AstraZeneca$194
- Pfizer$157
- plus $582 from 13 others
What the payments were for
- Food & beverage$2,40199%
- Education$221%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 48 | $555 |
| GSK | 11 | $325 |
| Novo Nordisk | 18 | $306 |
| Lilly USA, LLC | 18 | $302 |
| AstraZeneca | 6 | $194 |
| Pfizer | 6 | $157 |
| Sanofi-aventis U.S. LLC | 7 | $128 |
| Sunovion Pharmaceuticals Inc. | 8 | $115 |
| Amarin Pharma, Inc. | 5 | $85 |
| Novartis | 2 | $55 |
| Sanofi Pasteur Inc. | 3 | $46 |
| Abbott | 2 | $30 |
| Dexcom, Inc. | 2 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $17 |
| Eisai Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Mylan Specialty L.p. | 1 | $13 |
| Astellas Pharma US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$116
- BREZTRI AEROSPHERE$110
How this compares
$2,423 in reported general payments places this provider in the 75th percentile of 1,730 family medicine providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 79 | $99,729 |
| Tresiba Flextouch U-200Insulin Degludec | 44 | $86,182 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 60 | $73,798 |
| XareltoRivaroxaban | 17 | $28,575 |
| UbrelvyUbrogepant | 12 | $22,518 |
| Breo ElliptaFluticasone/Vilanterol | 32 | $21,999 |
| JanuviaSitagliptin Phosphate | 12 | $21,638 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 21 | $12,135 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 62 | $11,557 |
| TrulicityDulaglutide | 11 | $11,047 |
| Tresiba Flextouch U-100Insulin Degludec | 15 | $10,570 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 35 | $7,824 |
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 11 | $7,723 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 166 | $6,828 |
| Naproxen | 42 | $4,419 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Shingrix | $325 | $103,621127 claims |
| PfizerEliquis | $157 | $99,72979 claims |
| AbbVieUbrelvy, Synthroid | $555 | $23,46727 claims |
| Boehringer IngelheimCombivent Respimat | $17 | $12,13521 claims |
| Lilly USA, LLCTrulicity | $302 | $11,04711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,730 family medicine providers in Oklahoma.
Other family medicine in Oklahoma City
- Carl GriffinOklahoma City$28.2M
- Alexander FrankOklahoma City$3.1M
- Charles LunnOklahoma City$1.4M
- Hieu NguyenOklahoma City$238K
- Melinda CailOklahoma City$122K
- Jose Maria Borrego AcostaOklahoma City$106K
- Brett CauthenOklahoma City$77K
- Angelique BarretoOklahoma City$74K
- John PittmanOklahoma City$39K
- Terrence TruongOklahoma City$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.